---
title: "GT Biopharma (GTBP.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/GTBP.US/norm.md"
symbol: "GTBP.US"
name: "GT Biopharma"
parent: "https://longbridge.com/zh-HK/quote/GTBP.US.md"
datetime: "2026-05-20T19:09:12.735Z"
locales:
  - [en](https://longbridge.com/en/quote/GTBP.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GTBP.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GTBP.US/norm.md)
---

# GT Biopharma (GTBP.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1113 | -2.23 | -0.8268 | -0.5477 | -0.3309 |
| ROE | -201.66% | -2631.49% | -444.85% | -646.30% | 234.09% |
| 營業收入 | - | - | - | - | - |
| 凈利潤 | -3.37M | -28.90M | -3.26M | -1.52M | -776000.00 |
| 營業利潤 | -2.85M | -5.59M | -3.38M | -1.51M | -1.93M |
| 毛利率 | - | - | - | - | - |
| 凈利率 | - | - | - | - | - |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 10.00M | 8.11M | 4.32M | 7.12M | 2.66M |
| 權益乘數 | 1.32 | 1.40 | 1.44 | 1.48 | -2.71 |
| 每股凈資產 | 0.2154 | 0.2266 | 0.4955 | 0.8738 | -0.3868 |
| 資產周轉率 | - | - | - | - | - |
| 現金及短投 | 8.92M | 6.81M | 2.53M | 5.23M | 2.37M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | - | - | - | - | - |
| 凈債務 | -8.92M | -6.81M | -2.53M | -5.23M | -2.37M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -2.47M | -4.02M | -3.68M | -3.01M | -2.20M |
| 投資現金流 | - | - | - | - | - |
| 融資現金流 | 4.58M | 8.30M | 977000.00 | 5.88M | 616000.00 |
| 自由現金流 | -1.46M | -1.95M | -2.62M | -3.88M | -3.48M |
| 現金流充裕率 | - | -2792.36% | -4325.88% | - | - |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | - | - | - | - | - |